Clinical trial
Tetracaine Compared to Placebo for Reducing Pain With Palivizumab - A Pilot…
NCT00484393 · Fraser Health, Other · Completed
Key facts
| NCT number | NCT00484393 |
|---|---|
| Title | Tetracaine Compared to Placebo for Reducing Pain With Palivizumab - A Pilot Study |
| Official title | Tetracaine (Ametop®) Compared to Placebo for Reducing Pain Associated With Intramuscular Injection of Palivizumab (Synagis®) - A Pilot Study |
| Lead sponsor | Fraser Health, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | tetracaine 4% gel, Placebo |
| Enrollment | 7 |
| Start date | Nov 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jun 8, 2007 |
| Last update posted | Jun 19, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: